Breaking News

Adc Therapeutics SA (ADCT)

NYSE

Add to/Remove from a Portfolio Add to Watchlist

3.280 +0.050 +1.55%

25/07 - Closed. Currency in USD

Pre Market

3.280

0.000

0.00%

09:25:22 - Real-time Data

Type: Equity

Market: United States

Volume: 343,661
Bid/Ask: 0.000 / 0.000
Day's Range: 3.120 - 3.300

General
Chart
- Streaming charts
- Interactive Chart
News & Analysis
- News
- Analysis & Comment
Financials
Technical
Forum

Adc Therapeutics SA Company Profile

Get an in-depth profile of Adc Therapeutics SA, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

264

Equity Type

ORD

ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S. Food and Drug Administration, conditional approval from the European Commission, and conditional approval from the China National Medical Products Administration for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy. The company is also seeking to continue expanding ZYNLONTA into international markets and into earlier lines of DLBCL and indolent lymphomas, including follicular lymphoma (FL) and marginal zone lymphoma (MZL) as a single agent and in combination through its LOTIS-5 confirmatory Phase 3 clinical trial and LOTIS-7 Phase 1b clinical trial, as well as through investigator-initiated trials (IITs). In addition, it is investigating a CD-22 targeted compound’ and ADCT-602 that is in a Phase 1/2 IIT in refractory B-cell acute lymphoblastic leukemia. Further, the company’s pre-clinical stage pipeline includes a portfolio of next generation investigational ADCs targeting Claudin-6, NaPi2b, PSMA, NaPi2b, and ASCT2. ADC Therapeutics SA was incorporated in 2011 and is headquartered in Epalinges, Switzerland.

Contact Information

Address BiopOle Route de la Corniche 3B
Epalinges, 1066
Switzerland

Phone 41 21 653 02 00

Fax -

Web www.adctherapeutics.com

Top Executives

Name	Age	Since	Title
Ameet Mallik	51	2022	CEO & Director
Peter Hug	66	2019	Vice-Chairman & Lead Independent Director
Ron Squarer	57	2020	Chairman of the Board
Tyrell Rivers	52	2018	Independent Non-Executive Director
Victor Sandor	59	2020	Independent Non-Executive Director
Viviane Monges	62	2021	Independent Non-Executive Director
Robert William Azelby	57	2023	Independent Director
Jean-Pierre Bizzari	71	2022	Independent Non-Executive Director
Timothy P. Coughlin	58	2025	Director

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com Nigeria's comment guidelines and agree to the terms described.

I Agree

ADCT Comments

Write your thoughts about Adc Therapeutics SA

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d72-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d72-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

NSE 30	4,932.39	+44.05	+0.90%
NSE All Share	134,452.94	+1252.96	+0.94%
US 30	44,991.0	+89.1	+0.20%
US 500	6,410.6	+22.0	+0.34%
FTSE 100	9,134.45	+14.14	+0.16%
DAX	24,308.55	+75.47	+0.31%
South Africa Top 40	91,299.76	-3.64	0.00%

Brent Oil	68.04	+0.38	+0.56%
Crude Oil WTI	65.55	+0.39	+0.60%
Gold	3,393.56	+1.06	+0.03%
Silver	38.355	-0.010	-0.03%
Copper	5.7790	-0.0060	-0.10%
London Cocoa	5,485.00	+142.00	+2.66%
London Wheat	177.45	-0.25	-0.14%

Nigeria 10Y	15.954	-0.006	-0.04%
Nigeria 2Y	16.755	+0.001	+0.01%
U.K. 10Y	4.6100	-0.0220	-0.47%
Germany 10Y	2.6840	-0.0330	-1.21%
U.S. 10Y	4.371	-0.015	-0.34%
U.S. 5Y	3.945	-0.007	-0.18%
U.S. 2Y	3.915	-0.002	-0.05%

Fidelitybk	21.200	+0.600	+2.91%
Zenith Bank	74.00	+0.80	+1.09%
UBA	47.00	+0.45	+0.97%
First HoldCo	36.20	+1.05	+2.99%
Guaranty Trust Holding	94.00	-0.10	-0.11%
Sterling Bank	6.600	+0.200	+3.13%
Dangote Cement	493.00	+3.00	+0.61%

Recent Quotes

Name	Price	Chg.	Chg. %
ADCT	3.280	+0.050	+1.55%
PHARMa	0.9573	0.0000	0.00%
Yelin Lapidot 90/.	117.690	-0.090	-0.08%
RENA	34.49	+0.37	+1.08%
American Funds 20.	22.85	+0.05	+0.22%
Danske Invest Glo.	495.140	-0.150	-0.03%
Fidelity Funds - .	4.746	+0.005	+0.11%
MISTRAL INVERSION.	15.731	+0.042	+0.27%

Market Movers

Name	Last	Chg. %	Vol.
Access Holdings	27.70	-2.81%	42.42M
Guaranty Trust Holding	94.00	-0.11%	28.71M
Zenith Bank	74.00	+1.09%	16.96M
MTN Nigeria	400.00	+1.27%	3.44M
Okomu Oil Palm	998.00	+5.05%	2.58M
Presco	1,550.00	+7.68%	900.61K
Seplat Petroleum	5,450.00	0.00%	337.85K

Name	Last	Chg. %	Vol.
Champion Brew	12.32	+10.00%	1.69M
Unilever Nigeria	68.20	+10.00%	1.19M
Ikeja	23.100	+10.00%	3.01M
Nigerian Enamelware PLC	27.00	+9.98%	110.03K
Initiates	16.13	+9.95%	3.53M
Academy Press	9.31	+9.92%	2.12M
Prestige	1.23	+9.82%	13.85M

Name	Last	Chg. %	Vol.
Tripple Gee and Co	3.51	-10.00%	469.29K
Tantalizers	2.46	-8.55%	32.20M
Sunu Assurances	4.64	-6.64%	18.84M
ETI	32.00	-5.88%	4.55M
Neimeth	6.50	-4.55%	7.07M
Rtbriscoe	3.58	-4.53%	5.90M
Linkassure	1.50	-3.23%	894.80K